Exchange Traded Concepts, LLC Harmony Biosciences Holdings, Inc. Transaction History

Exchange Traded Concepts, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$28.81 - $33.01 $48,055 - $55,060	1,668 Added 6.24%	28,393 $856,000
Q1 2024 Apr 15, 2024	SELL	$29.93 - $35.06 $423,928 - $496,589	-14,164 Reduced 34.64%	26,725 $897,000
Q4 2023 Jan 05, 2024	BUY	$19.2 - $33.78 $6,297 - $11,079	328 Added 0.81%	40,889 $1.32 Million
Q3 2023 Oct 18, 2023	BUY	$31.89 - $39.03 $1.28 Million - $1.57 Million	40,163 Added 10091.21%	40,561 $1.33 Million
Q2 2023 Jul 20, 2023	SELL	$30.5 - $37.4 $213 - $261	-7 Reduced 1.73%	398 $14,000
Q1 2023 Apr 12, 2023	BUY	$30.8 - $53.92 $12,474 - $21,837	405 New	405 $13,000

242

45.1M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.